keyword
https://read.qxmd.com/read/37188495/-a-point-mutation-at-c151-of-keap1-of-mice-abrogates-nrf2-signaling-cytoprotection-in-vitro-and-hepatoprotection-in-vivo-by-bardoxolone-methyl-cddo-me
#21
JOURNAL ARTICLE
Tonibelle Gatbonton-Schwager, Yoko Yagishita, Tanvi Joshi, Nobunao Wakabayashi, Harini Srinivasan, Takafumi Suzuki, Masayuki Yamamoto, Thomas W Kensler
Bardoxolone methyl (CDDO-Me) is an oleanane triterpenoid in late-stage clinical development for the treatment of patients with diabetic kidney disease. Preclinical studies in rodents demonstrate the efficacy of triterpenoids against carcinogenesis and other diseases including renal ischemia-reperfusion injury, hyperoxia-induced acute lung injury and immune hepatitis. Genetic disruption of NRF2 abrogates protection by triterpenoids, suggesting that induction of the NRF2 pathway may drive this protection. Herein, we examined the effect of a point mutation (C151S) in KEAP1, a repressor of NRF2 signaling, at cysteine 151 in mouse embryo fibroblasts and mouse liver...
May 15, 2023: Molecular Pharmacology
https://read.qxmd.com/read/37131828/a-core-nrf2-gene-set-defined-through-comprehensive-transcriptomic-analysis-predicts-drug-resistance-and-poor-multi-cancer-prognosis
#22
George Luo, Harshita Kumar, Kristin Aldridge, Stevie Rieger, Ethan Jiang, Ernest R Chan, Ahmed Soliman, Haider Mahdi, John J Letterio
UNLABELLED: The Nrf2-KEAP1 pathway plays an important role in the cellular response to oxidative stress and confers protection in diseases associated with chronic inflammation. However, chronic activation of the Nrf2 pathway may contribute to metabolic changes and disease progression in cancer. We investigated the activation of Nrf2 in human cancers and fibroblast cells through KEAP1 inhibition and cancer associated KEAP1/Nrf2 mutations. We define a core set of 14 upregulated Nrf2 target genes from seven RNA-Sequencing databases that we generated and analyzed...
April 21, 2023: bioRxiv
https://read.qxmd.com/read/37077825/synthetic-oleanane-triterpenoids-suppress-myb-oncogene-activity-and-sensitize-t-cell-acute-lymphoblastic-leukemia-cells-to-chemotherapy
#23
JOURNAL ARTICLE
Paloma Tejera Nevado, Tajana Tešan Tomić, Ali Atefyekta, André Fehr, Göran Stenman, Mattias K Andersson
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy with poor prognosis. The MYB oncogene encodes a master transcription factor that is activated in the majority of human T-ALLs. In the present study, we have performed a large-scale screening with small-molecule drugs to find clinically useful inhibitors of MYB gene expression in T-ALL. We identified several pharmacological agents that potentially could be used to treat MYB-driven malignancies. In particular, treatment with the synthetic oleanane triterpenoids (OTs) bardoxolone methyl and omaveloxolone decreased MYB gene activity and expression of MYB downstream target genes in T-ALL cells with constitutive MYB gene activation...
2023: Frontiers in Oncology
https://read.qxmd.com/read/37060561/complementary-gene-regulation-by-nrf1-and-nrf2-protects-against-hepatic-cholesterol-overload
#24
JOURNAL ARTICLE
May G Akl, Lei Li, Raquel Baccetto, Sadhna Phanse, Qingzhou Zhang, Michael J Trites, Sherin McDonald, Hiroyuki Aoki, Mohan Babu, Scott B Widenmaier
Hepatic cholesterol overload promotes steatohepatitis. Insufficient understanding of liver stress defense impedes therapy development. Here, we elucidate the role of stress defense transcription factors, nuclear factor erythroid 2 related factor-1 (NRF1) and -2 (NRF2), in counteracting cholesterol-linked liver stress. Using a diet that increases liver cholesterol storage, expression profiles and phenotypes of liver from mice with hepatocyte deficiency of NRF1, NRF2, or both are compared with controls, and chromatin immunoprecipitation sequencing is undertaken to identify target genes...
April 14, 2023: Cell Reports
https://read.qxmd.com/read/37028547/oxidative-stress-as-a-culprit-in-diabetic-kidney-disease
#25
REVIEW
Sensen Su, Zhanchuan Ma, Hao Wu, Zhonggao Xu, Huanfa Yi
Diabetic kidney disease (DKD) has become the leading cause of end-stage renal disease (ESRD), and the prevalence of DKD has increased worldwide during recent years. DKD is associated with poor therapeutic outcomes in most patients, but there is limited understanding of its pathogenesis. This review suggests that oxidative stress interacts with many other factors in causing DKD. Highly active mitochondria and NAD(P)H oxidase are major sources of oxidants, and they significantly affect the risk for DKD. Oxidative stress and inflammation may be considered reciprocal causes of DKD, in that each is a cause and an effect of DKD...
June 1, 2023: Life Sciences
https://read.qxmd.com/read/36992362/inhibitors-of-the-ubiquitin-mediated-signaling-pathway-exhibit-broad-spectrum-antiviral-activities-against-new-world-alphaviruses
#26
JOURNAL ARTICLE
Niloufar A Boghdeh, Brittany McGraw, Michael D Barrera, Carol Anderson, Haseebullah Baha, Kenneth H Risner, Ifedayo V Ogungbe, Farhang Alem, Aarthi Narayanan
New World alphaviruses including Venezuelan Equine Encephalitis Virus (VEEV) and Eastern Equine Encephalitis Virus (EEEV) are mosquito-transmitted viruses that cause disease in humans and equines. There are currently no FDA-approved therapeutics or vaccines to treat or prevent exposure-associated encephalitic disease. The ubiquitin proteasome system (UPS)-associated signaling events are known to play an important role in the establishment of a productive infection for several acutely infectious viruses. The critical engagement of the UPS-associated signaling mechanisms by many viruses as host-pathogen interaction hubs led us to hypothesize that small molecule inhibitors that interfere with these signaling pathways will exert broad-spectrum inhibitory activity against alphaviruses...
February 28, 2023: Viruses
https://read.qxmd.com/read/36982949/cddo-me-abrogates-aberrant-mitochondrial-elongation-in-clasmatodendritic-degeneration-by-regulating-nf-%C3%AE%C2%BAb-pdi-mediated-s-nitrosylation-of-drp1
#27
JOURNAL ARTICLE
Duk-Shin Lee, Tae-Hyun Kim, Hana Park, Ji-Eun Kim
Clasmatodendrosis is a kind of astroglial degeneration pattern which facilitates excessive autophagy. Although abnormal mitochondrial elongation is relevant to this astroglial degeneration, the underlying mechanisms of aberrant mitochondrial dynamics are still incompletely understood. Protein disulfide isomerase (PDI) is an oxidoreductase in the endoplasmic reticulum (ER). Since PDI expression is downregulated in clasmatodendritic astrocytes, PDI may be involved in aberrant mitochondrial elongation in clasmatodendritic astrocytes...
March 20, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36874247/bardoxolone-methyl-ameliorates-myocardial-ischemia-reperfusion-injury-by-activating-the-nrf2-ho-1-signaling-pathway
#28
JOURNAL ARTICLE
Anwu Huang, Zhaolin Wang, Hua Tang, Zhuyin Jia, Xiaojun Ji, Xuehua Yang, Wenbing Jiang
BACKGROUND: Myocardial ischemia/reperfusion (I/R) injury is a severe heart problem resulting from restoring coronary blood flow to the myocardium after ischemia. This study is aimed at ascertaining the therapeutic efficiency and action mechanism of bardoxolone methyl (BARD) in myocardial I/R injury. METHODS: In male rats, myocardial ischemia was performed for 0.5 h, and then, reperfusion lasted for 24 h. BARD was administrated in the treatment group...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/36798782/bardoxolone-methyl-ameliorates-osteoarthritis-by-inhibiting-osteoclastogenesis-and-protecting-the-extracellular-matrix-against-degradation
#29
JOURNAL ARTICLE
Ruijia Yang, Yanjing Guo, Sujing Zong, Zhou Ma, Zhenyu Wang, Jiyu Zhao, Jinmei Yang, Liping Li, Chongwei Chen, Shaowei Wang
Inflammation and oxidative damage are closely related to the development of osteoarthritis. Bardoxolone methyl (CDDO-Me), a semisynthetic oleanane triterpenoid, plays a strong anti-inflammatory and antioxidant role. The purpose of our research was to explore fundamental mechanisms of CDDO-Me in orthopaedics development. The results showed that CDDO-Me inhibited nuclear factor-κB ligand (RANKL)-induced osteoclast formation and extracellular matrix (ECM) degradation by activating the Nrf2/HO-1 signaling pathways and inhibiting NF-κB pathway activation and excess ROS production...
February 2023: Heliyon
https://read.qxmd.com/read/36731435/the-cardinal-trial-of-bardoxolone-methyl-in-alport-syndrome-when-marketing-interests-prevail-over-patients-clinical-needs
#30
JOURNAL ARTICLE
Piero Ruggenenti
Alport syndrome (AS) is a hereditary chronic kidney disease (CKD) with X-linked, autosomal and digenic patterns of transmission. Sieving dysfunction of the glomerular basement membrane caused by congenitally defective type IV collagen results in persistent proteinuria, hematuria and progressive renal dysfunction. There are no disease-specific medications and treatment is based on conservative interventions in particular with renin-angiotensin-aldosterone system inhibitors. Subject of Review. Evidence that AS is accompanied by glomerular and tubular inflammatory changes and that bardoxolone methyl exerts anti-inflammatory effects through suppression of NF-kB and activation of transcription of antioxidant and anti-inflammatory genes, provided a justification for the CARDINAL study, a prospective, randomized controlled trial testing the potential renoprotective effect of bardoxolone methyl in 157 adolescent or adult patients with AS...
February 2, 2023: Nephron
https://read.qxmd.com/read/36730842/nuclear-factor-erythroid-2-related-factor-regulates-systemic-and-pulmonary-barrier-function-and-immune-programming-after-burn-and-inhalation-injury
#31
JOURNAL ARTICLE
Roland F Seim, Michelle Mac, Lucas M Sjeklocha, Alex J Kwiatkowski, Ben G Keselowsky, Shannon M Wallet, Bruce A Cairns, Robert Maile
Major burn injury is associated with systemic hyper-inflammatory and oxidative stresses that encompass the wound, vascular, and pulmonary systems that contribute to complications and poor outcomes. These stresses are exacerbated if there is a combined burn and inhalation injury (B + I), which leads to increases in morbidity and mortality. Nuclear Factor-Erythroid-2-Related Factor (NRF2) is a transcription factor that functions to maintain homeostasis during stress, in part by modulating inflammation and oxidative injury...
November 3, 2022: Shock
https://read.qxmd.com/read/36691556/activation-of-nrf2-blocks-hiv-replication-and-apoptosis-in-macrophages
#32
JOURNAL ARTICLE
Dating Han, Xiangyun Lu, Wanpeng Yin, Haijing Fu, Xiaodi Zhang, Linfang Cheng, Fuming Liu, Changzhong Jin, Xuebin Tian, Yiwen Xie, Nanping Wu
Abnormal oxidative stress caused by human immunodeficiency virus (HIV) infection affects viral replication and causes non-acquired immune deficiency syndrome-related complications in infected individuals. The transcription factor NFE2-related factor 2 (NRF2), a key regulator of oxidative stress, responds to abnormal oxidative stress by regulating the expression of NRF2-dependent cytoprotective genes. The present study aimed to determine whether inhibition of oxidative stress could control HIV replication and improve cell survival...
January 2023: Heliyon
https://read.qxmd.com/read/36670978/the-triterpenoid-cddo-methyl-ester-redirects-macrophage-polarization-and-reduces-lung-tumor-burden-in-a-nrf2-dependent-manner
#33
JOURNAL ARTICLE
Jessica A Moerland, Ana S Leal, Beth Lockwood, Elena Y Demireva, Huirong Xie, Teresa Krieger-Burke, Karen T Liby
The NRF2/KEAP1 pathway protects healthy cells from malignant transformation and maintains cellular homeostasis. Up to 30% of human lung tumors gain constitutive NRF2 activity which contributes to cancer cell survival and chemoresistance, but the effects of NRF2 activation in immune cells within the tumor microenvironment are underexplored. Macrophages can promote cancer progression or regression depending on context, and NRF2 activation affects macrophage activity. The NRF2 activator CDDO-Methyl ester (CDDO-Me or bardoxolone methyl) reprogrammed Nrf2 wild-type (WT) tumor-educated bone marrow-derived macrophages (TE-BMDMs) from a tumor-promoting to a tumor-inhibiting phenotype, marked by an increase in M1 markers TNFα, IL-6, and MHC-II and a decrease in the tumor-promoting factors VEGF, CCL2, and CD206...
January 3, 2023: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/36660586/combining-metformin-and-drug-loaded-kidney-targeting-micelles-for-polycystic-kidney-disease
#34
JOURNAL ARTICLE
Kairui Jiang, Yi Huang, Eun Ji Chung
INTRODUCTION: Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease that leads to eventual renal failure. Metformin (MET), an AMP-activated protein kinase (AMPK) activator already approved for type 2 diabetes, is currently investigated for ADPKD treatment. However, despite high tolerability, MET showed varying therapeutic efficacy in preclinical ADPKD studies. Thus, newer strategies have combined MET with other ADPKD small molecule drug candidates, thereby targeting multiple ADPKD-associated signaling pathways to enhance therapeutic outcomes through potential drug synergy...
February 2023: Cellular and Molecular Bioengineering
https://read.qxmd.com/read/36551877/emr1-adgre1-expression-in-cancer-cells-upregulated-by-tumor-associated-macrophages-is-related-to-poor-prognosis-in-colorectal-cancer
#35
JOURNAL ARTICLE
Rokeya Akter, Kwangmin Kim, Hye Youn Kwon, Youngwan Kim, Young Woo Eom, Hye-Mi Cho, Mee-Yon Cho
EMR1, a member of the adhesion G protein-coupled receptor family (ADGRE1), is a macrophage marker that is abnormally expressed in cancer cells. However, its clinical significance in colorectal cancer (CRC) is not well-known. In this investigation, EMR1 expression in tumor cells (EMR1-TC) was found in 91 (22.8%) of the 399 CRC samples tested by immunohistochemical staining and showed a significant relationship with lymph node metastasis. Furthermore, EMR1-TC was significantly associated with CD68+ CD163+ tumor-associated macrophages (TAMs), and CRC with a high combined EMR1-TC+ CD68+ CD163+ score showed worse recurrence-free survival prognosis...
December 2, 2022: Biomedicines
https://read.qxmd.com/read/36514415/bardoxolone-for-ckd-the-paradox-of-confusion-and-dogma
#36
JOURNAL ARTICLE
Uma Mahesh R Avula, Liliia Harris, Mohamed Hassanein
No abstract text is available yet for this article.
November 24, 2022: Kidney360
https://read.qxmd.com/read/36450526/oxidized-albumin-evaluation-of-oxidative-stress-as-a-marker-for-the-progression-of-kidney-disease
#37
JOURNAL ARTICLE
Hiroshi Watanabe
Oxidative stress has been reported to be associated with the progression of renal pathology as well as with the onset of complications associated with this condition. Bardoxolone methyl, a nuclear factor-erythroid 2-related factor 2 (Nrf2) activator with anti-oxidative and inflammatory modulation effects, has been reported to improve renal function in clinical trials. As of this writing, there have been no systems for the quantitative evaluation of oxidative stress that could be applied as a clinical test. We recently reported on post-translational modifications of albumin using electrospray-ionization time-of-flight mass spectrometry (ESI-TOF MS) and the results indicated that oxidized albumin (cysteinylated albumin: a molecule that was oxidatively cysteinylated at Cys34) was found to increase with the progression of renal pathology...
2022: Biological & Pharmaceutical Bulletin
https://read.qxmd.com/read/36411059/bardoxolone-methyl-for-alport-syndrome-opportunities-and-challenges
#38
EDITORIAL
Catherine Quinlan, Kushani Jayasinghe
No abstract text is available yet for this article.
December 2022: Clinical Journal of the American Society of Nephrology: CJASN
https://read.qxmd.com/read/36411058/effects-of-bardoxolone-methyl-in-alport-syndrome
#39
RANDOMIZED CONTROLLED TRIAL
Bradley A Warady, Pablo E Pergola, Rajiv Agarwal, Sharon Andreoli, Gerald B Appel, Sripal Bangalore, Geoffrey A Block, Arlene B Chapman, Melanie P Chin, Keisha L Gibson, Angie Goldsberry, Kazumoto Iijima, Lesley A Inker, Clifford E Kashtan, Bertrand Knebelmann, Laura H Mariani, Colin J Meyer, Kandai Nozu, Megan O'Grady, Michelle N Rheault, Arnold L Silva, Peter Stenvinkel, Roser Torra, Glenn M Chertow
BACKGROUND AND OBJECTIVES: Alport syndrome is an inherited disease characterized by progressive loss of kidney function. We aimed to evaluate the safety and efficacy of bardoxolone methyl in patients with Alport syndrome. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We randomly assigned patients with Alport syndrome, ages 12-70 years and eGFR 30-90 ml/min per 1.73 m2 , to bardoxolone methyl ( n =77) or placebo ( n =80). Primary efficacy end points were change from baseline in eGFR at weeks 48 and 100...
December 2022: Clinical Journal of the American Society of Nephrology: CJASN
https://read.qxmd.com/read/36291647/activation-of-nrf2-to-optimise-immune-responses-to-intracerebral-haemorrhage
#40
REVIEW
James J M Loan, Rustam Al-Shahi Salman, Barry W McColl, Giles E Hardingham
Haemorrhage into the brain parenchyma can be devastating. This manifests as spontaneous intracerebral haemorrhage (ICH) after head trauma, and in the context of vascular dementia. Randomised controlled trials have not reliably shown that haemostatic treatments aimed at limiting ICH haematoma expansion and surgical approaches to reducing haematoma volume are effective. Consequently, treatments to modulate the pathophysiological responses to ICH, which may cause secondary brain injury, are appealing. Following ICH, microglia and monocyte derived cells are recruited to the peri-haematomal environment where they phagocytose haematoma breakdown products and secrete inflammatory cytokines, which may trigger both protective and harmful responses...
October 7, 2022: Biomolecules
keyword
keyword
52654
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.